Global News

Merck Serono, Compugen establish new biomarker company Neviah Genomics

Monday, June 25, 2012 02:52 PM

Merck Serono of Darmstadt, Germany, and Compugen, a therapeutic product discovery company of Tel Aviv, Israel, have established a novel start-up company called Neviah Genomics, focused on the discovery and development of novel biomarkers for the prediction of drug-induced toxicity.

More... »

RainDance and MLL collaborate on sequence-based analysis of myeloid malignancies

Monday, June 25, 2012 10:56 AM

MLL Munich Leukemia Laboratory (MLL) has purchased RainDance Technologies’ ThunderStorm System and consumables to process an initial 2,000 samples for use in the identification of prognostically relevant molecular mutations associated with acute myeloid leukemia (AML) and other myeloid malignancies.

More... »

Patient Recruiters International opens office in Southeast Asia

Monday, June 25, 2012 09:46 AM

Patient Recruiters International (PRI), a provider of direct patient access solutions for patient recruitment, has opened its new Southeast Asian office in Bangkok, Thailand.

More... »

First artificial pancreas trial testing in patients' homes at night

Friday, June 22, 2012 02:59 PM

For the first time ever, two patients with diabetes were successfully treated overnight in their own homes with the MD-Logic Artificial Pancreas (MD-Logic) system, developed by specialists at Schneider Children's Medical Center of Israel. The test is a major step towards the development of a commercial device for night-time automatic control of a patient's blood glucose levels at home.

More... »

CytoPharm, Amarillo report positive results in phase II HCV

Friday, June 22, 2012 02:24 PM

Taiwan-based pharmaceutical company CytoPharm and Texas-based biotech Amarillo Biosciences released positive clinical findings from a dose-ranging, phase II clinical trial of patients infected with hepatitis C virus (HCV) in Taiwan.

More... »

MJFF launches $14M Edmond J. Safra Core programs for Parkinson’s research

Friday, June 22, 2012 01:00 PM

The Michael J. Fox Foundation for Parkinson's Research (MJFF) has officially opened its Therapeutic Pipeline Program, a newly created funding mechanism that invites research proposals from industry and academic investigators to drive pre-clinical and clinical Parkinson's disease (PD) drug development.

More... »

Survey: Pharma execs focus on regulation and organic growth

Friday, June 22, 2012 12:09 PM

Pharmaceutical executives say they will focus as much time and energy ahead in navigating the regulatory environment as they will on organic growth, according to a recent survey by KPMG, the U.S. audit, tax and advisory firm.

More... »

Quanticate launches next generation FSP service

Friday, June 22, 2012 07:30 AM

Quanticate, a global data-focused CRO based in both the U.S. and U.K., has unveiled its next generation functional service provision (FSP) service to support customers through integrating centralization across functions.

More... »

AstraZeneca, Karolinska Institutet collaborate on molecular imaging research

Thursday, June 21, 2012 04:29 PM

Global biopharmaceutical company AstraZeneca and Karolinska Institutet, a medical university in Sweden, have entered into a three year collaborative research agreement that will apply state-of-the-art molecular imaging technologies to generate novel diagnostic imaging tools and further the development of AstraZeneca’s neuroscience R&D pipeline.

More... »

ExecuPharm expands to U.K. and Argentina

Thursday, June 21, 2012 02:49 PM

ExecuPharm, a staffing and functional service providers (FSP) specializing solely in the clinical research industry, recently expanded its locations to include Europe and Latin America.

More... »